tiprankstipranks
Trending News
More News >
Rennova Health (RNVA)
OTHER OTC:RNVA
US Market

Rennova Health (RNVA) Ratios

Compare
224 Followers

Rennova Health Ratios

RNVA's free cash flow for Q4 2023 was $0.48. For the 2023 fiscal year, RNVA's free cash flow was decreased by $ and operating cash flow was $-0.56. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.16 0.16 0.13 0.10 0.05
Quick Ratio
0.16 0.16 0.12 0.10 0.04
Cash Ratio
<0.01 <0.01 0.01 0.02 <0.01
Solvency Ratio
-0.13 -0.13 -0.06 -0.25 -0.28
Operating Cash Flow Ratio
0.08 0.08 >-0.01 -0.19 -0.28
Short-Term Operating Cash Flow Coverage
1.06 1.06 -0.02 -0.59 -0.86
Net Current Asset Value
$ -50.15M$ -50.15M$ -43.30M$ -42.22M$ -58.56M
Leverage Ratios
Debt-to-Assets Ratio
0.58 0.58 0.75 0.82 1.80
Debt-to-Equity Ratio
-0.32 -0.32 -0.53 -0.59 -0.45
Debt-to-Capital Ratio
-0.47 -0.47 -1.11 -1.43 -0.82
Long-Term Debt-to-Capital Ratio
-0.29 -0.29 0.00 0.00 -0.03
Financial Leverage Ratio
-0.55 -0.55 -0.71 -0.72 -0.25
Debt Service Coverage Ratio
0.26 0.26 -0.03 -0.06 -0.24
Interest Coverage Ratio
0.94 0.94 -0.62 -1.65 -1.75
Debt to Market Cap
2.65 3.48 1.45K 273.85K 5.31M
Interest Debt Per Share
<0.01 <0.01 <0.01 35.09 106.66M
Net Debt to EBITDA
8.09 8.09 -63.16 -12.14 -2.62
Profitability Margins
Gross Profit Margin
59.46%59.46%48.08%-64.16%-63.66%
EBIT Margin
6.09%6.09%-5.40%-59.15%-126.54%
EBITDA Margin
7.76%7.76%-1.80%-39.19%-116.81%
Operating Profit Margin
7.31%7.31%-10.81%-163.54%-238.82%
Pretax Profit Margin
-1.68%-1.68%-22.72%-388.37%-263.22%
Net Profit Margin
-41.36%-41.36%-25.26%-382.80%-245.05%
Continuous Operations Profit Margin
-2.96%-2.96%-25.12%-163.54%-245.05%
Net Income Per EBT
2461.17%2461.17%111.19%98.57%93.10%
EBT Per EBIT
-22.99%-22.99%210.12%237.47%110.22%
Return on Assets (ROA)
-38.16%-38.16%-16.01%-62.85%-143.89%
Return on Equity (ROE)
23.45%20.99%11.32%45.20%35.99%
Return on Capital Employed (ROCE)
-6.14%-6.14%4.91%19.73%36.65%
Return on Invested Capital (ROIC)
-12.76%-12.76%11.14%46.22%59.47%
Return on Tangible Assets
-38.66%-38.66%-16.21%-63.69%-147.00%
Earnings Yield
-235.46%-235.46%-32956.13%-22504579.88%-450868635.31%
Efficiency Ratios
Receivables Turnover
2.81 2.81 2.41 0.90 3.75
Payables Turnover
0.61 0.61 0.59 0.44 0.83
Inventory Turnover
38.23 38.23 27.89 18.87 26.46
Fixed Asset Turnover
3.99 3.99 2.73 0.59 0.82
Asset Turnover
0.92 0.92 0.63 0.16 0.59
Working Capital Turnover Ratio
-0.48 -0.48 -0.31 -0.07 -0.11
Cash Conversion Cycle
-456.65 -456.65 -456.54 -410.79 -330.34
Days of Sales Outstanding
129.96 129.96 151.35 406.79 97.32
Days of Inventory Outstanding
9.55 9.55 13.09 19.35 13.80
Days of Payables Outstanding
596.16 596.16 620.98 836.92 441.46
Operating Cycle
139.51 139.51 164.44 426.13 111.11
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 <0.01 >-0.01 -16.25 -56.21M
Free Cash Flow Per Share
<0.01 <0.01 >-0.01 -16.25 -57.17M
CapEx Per Share
<0.01 <0.01 <0.01 0.00 967.08K
Free Cash Flow to Operating Cash Flow
0.90 0.90 1.16 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
9.65 9.65 -6.20 0.00 -58.12
Capital Expenditure Coverage Ratio
9.65 9.65 -6.20 0.00 -58.12
Operating Cash Flow Coverage Ratio
0.29 0.29 -0.01 -0.56 -0.76
Operating Cash Flow to Sales Ratio
0.18 0.18 -0.02 -2.76 -2.33
Free Cash Flow Yield
70.54%92.52%-2537.75%-16252837.01%-436448776.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.42 -0.42 >-0.01 >-0.01 >-0.01
Price-to-Sales (P/S) Ratio
0.23 0.18 <0.01 <0.01 <0.01
Price-to-Book (P/B) Ratio
-0.09 -0.09 >-0.01 >-0.01 >-0.01
Price-to-Free Cash Flow (P/FCF) Ratio
1.42 1.08 -0.04 >-0.01 >-0.01
Price-to-Operating Cash Flow Ratio
0.97 0.97 -0.05 >-0.01 >-0.01
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 <0.01 <0.01 <0.01
Price-to-Fair Value
-0.09 -0.09 >-0.01 >-0.01 >-0.01
Enterprise Value Multiple
11.06 10.36 -63.20 -12.14 -2.62
Enterprise Value
16.03M 15.01M 14.84M 15.33M 22.00M
EV to EBITDA
11.06 10.36 -63.20 -12.14 -2.62
EV to Sales
0.86 0.80 1.14 4.76 3.05
EV to Free Cash Flow
5.28 4.94 -58.52 -1.72 -1.29
EV to Operating Cash Flow
4.73 4.43 -67.96 -1.72 -1.31
Tangible Book Value Per Share
>-0.01 >-0.01 >-0.01 -50.26 -164.96M
Shareholders’ Equity Per Share
>-0.01 >-0.01 >-0.01 -49.79 -164.09M
Tax and Other Ratios
Effective Tax Rate
-0.76 -0.76 -0.11 0.01 0.07
Revenue Per Share
<0.01 <0.01 <0.01 5.88 24.10M
Net Income Per Share
>-0.01 >-0.01 >-0.01 -22.50 -59.06M
Tax Burden
24.61 24.61 1.11 0.99 0.93
Interest Burden
-0.28 -0.28 4.21 6.57 2.08
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.50 0.50 0.53 2.33 1.62
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-6.12 -6.12 0.07 1.69 0.95
Currency in USD